---
title: "BLAC.US (BLAC.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BLAC.US/news.md"
symbol: "BLAC.US"
name: "BLAC.US"
parent: "https://longbridge.com/en/quote/BLAC.US.md"
datetime: "2026-03-14T06:29:48.455Z"
locales:
  - [en](https://longbridge.com/en/quote/BLAC.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BLAC.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BLAC.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/BLAC.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BLAC.US/news.md)


# BLAC.US (BLAC.US) — Related News

### [REG - Bellevue Healthcare - Net Asset Value(s)](https://longbridge.com/en/news/276432883.md)
*2026-02-20T10:28:19.000Z*
> Bellevue Healthcare Trust plc announced its unaudited net asset value (NAV) per ordinary share as of 19 February 2026. T

### [LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories | BBCMF Stock News](https://longbridge.com/en/news/275043764.md)
*2026-02-05T15:00:00.000Z*
> LIR Life Sciences Corp. has initiated Project Phase 2 of its peptide design program in collaboration with Neuland Labora

### [Lir Life Sciences Unveils Positive Interim Results for Needle-Free GLP-1 Patch in Obesity Therapy Trial](https://longbridge.com/en/news/274303498.md)
*2026-01-30T11:51:57.000Z*
### [LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies | BBCMF Stock News](https://longbridge.com/en/news/274216879.md)
*2026-01-29T15:00:00.000Z*
> LIR Life Sciences Corp. announced positive interim results from a comparative mouse study on a CPP-enabled, needle-free 

### [Bellevue Life Sciences Acquisition : OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp - Form 8-K](https://longbridge.com/en/news/102621719.md)
*2023-11-16T21:39:03.000Z*
> (marketscreener.com) OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acqui